Business Context and Reporting Period
Company: Healthcare Triangle, Inc. (HCTI)
Filing Type: Form 8-K (Current Report)
Date of Report: September 15, 2025
Reporting Period: Event-based report regarding regulatory compliance and investor communications.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses on regulatory status and corporate governance matters.
Material Changes and Regulatory Status
- NASDAQ Compliance Regained: The Company received notice from Nasdaq on September 15, 2025, confirming it has regained compliance with Listing Rule 5635(a)(1).
- Background of Non-Compliance: The Company previously failed to obtain shareholder approval for an issuance of approximately 345,622,120 shares (pre-split) representing 33.8% of pre-transaction outstanding stock for the acquisition of Niyama Healthcare, Inc. and Ezovion Solutions Private Limited.
- Resolution: On August 28, 2025, the acquisition agreement was amended to condition the share issuance upon shareholder approval. Nasdaq determined no further action is required, and the Company remains in compliance with all listing requirements.
Guidance, Outlook, and Risks
- Investor Presentation: The Company is furnishing an Investor Presentation (Exhibit 99.1) containing updates on operations, strategic plans, growth initiatives, and forecasts. This information is not deemed "filed" under the Exchange Act.
- Forward-Looking Statements: The filing includes standard disclaimers regarding forward-looking statements, noting that actual results may differ due to risks including the ability to appeal delisting determinations or secure OTCQB trading approval if delisted.
- Emerging Growth Company: The Company is identified as an emerging growth company.
Investor Verification Checklist
- Verify the terms of the amended acquisition agreement dated August 28, 2025, regarding the condition of shareholder approval.
- Review the attached Investor Presentation (Exhibit 99.1) for specific operational updates and forward-looking forecasts.
- Confirm the status of the 1-for-249 reverse stock split mentioned in the context of the share issuance calculation.
- Monitor upcoming shareholder meetings to ensure the required approval for the Niyama Healthcare and Ezovion Solutions acquisition is obtained.